1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL ADVANCEMENTS
5. EUROPE DRUG DELIVERY MARKET BY TYPE
5.1. Introduction
5.2. Inhalation Drug Delivery
5.3. Injectable Drug Delivery
5.4. Nasal Drug Delivery
5.5. Oral Drug Delivery
5.6. Transdermal Drug Delivery
6. EUROPE DRUG DELIVERY MARKET BY APPLICATION
6.1. Introduction
6.2. Treatment of diseases
6.3. Research/Academic purposes
7. EUROPE DRUG DELIVERY MARKET BY GEOGRAPHY
7.1. Introduction
7.2. U.K.
7.2.1. By Type
7.2.2. By Application
7.3. Germany
7.3.1. By Type
7.3.2. By Application
7.4. Switzerland
7.4.1. By Type
7.4.2. By Application
7.5. France
7.5.1. By Type
7.5.2. By Application
7.6. Spain
7.6.1. By Type
7.6.2. By Application
7.7. Italy
7.7.1. By Type
7.7.2. By Application
7.8. Others
7.8.1. By Type
7.8.2. By Application
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Ascendis Pharma A/S
9.2. Pfizer Inc.
9.3. Becton, Dickinson Company
9.4. Baxter International Inc.
9.5. Novartis
9.6. Bayer AG
9.7. Antares Pharma
9.8. Roche Holding
9.9. Novo Nordisk
9.10. GlaxoSmithKline
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations